Cailin E. Deal - Publications
Affiliations: | 2014-2019 | The Ragon Institute of MGH, MIT and Harvard | Harvard University, Cambridge, MA, United States |
Year | Citation | Score | |||
---|---|---|---|---|---|
2015 | Deal CE, Balazs AB. Engineering humoral immunity as prophylaxis or therapy. Current Opinion in Immunology. 35: 113-22. PMID 26183209 DOI: 10.1016/J.Coi.2015.06.014 | 0.744 | |||
2015 | Deal CE, Balazs AB. Vectored antibody gene delivery for the prevention or treatment of HIV infection. Current Opinion in Hiv and Aids. 10: 190-7. PMID 25700206 DOI: 10.1097/Coh.0000000000000145 | 0.763 | |||
2015 | Karen KA, Deal C, Adams RJ, Nielsen C, Ward C, Espinosa DA, Xie J, Zavala F, Ketner G. A replicating adenovirus capsid display recombinant elicits antibodies against Plasmodium falciparum sporozoites in Aotus nancymaae monkeys. Infection and Immunity. 83: 268-75. PMID 25368113 DOI: 10.1128/Iai.02626-14 | 0.573 | |||
2014 | Deal C, Balazs AB, Espinosa DA, Zavala F, Baltimore D, Ketner G. Vectored antibody gene delivery protects against Plasmodium falciparum sporozoite challenge in mice. Proceedings of the National Academy of Sciences of the United States of America. 111: 12528-32. PMID 25114213 DOI: 10.1073/Pnas.1407362111 | 0.719 | |||
2013 | Deal C, Pekosz A, Ketner G. Prospects for oral replicating adenovirus-vectored vaccines. Vaccine. 31: 3236-43. PMID 23707160 DOI: 10.1016/J.Vaccine.2013.05.016 | 0.427 | |||
Show low-probability matches. |